Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results

QR Code

Prevalence of non-alcoholic fatty liver disease in out-patients of the Russian Federation: DIREG 2 study results

Aim of investigation. Primary objective: to estimate the prevalence of NAFLD within the general practitioner’s and gastroenterologist’s patient flow.Materials and methods. The prospective disease registry was carried out as epidemiologic, observational, cross-sectional, multicenter investigation to...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. T. Ivashkin, O. M. Drapkina, I. V. Mayev, A. S. Trukhmanov, D. V. Blinov, L. K. Palgova, V. V. Tsukanov, T. I. Ushakova
Format:	Article
Language:	Russian
Published:	Gastro LLC 2015-12-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	direg 2, epidemiology, nafld, nonalcoholic fatty liver disease, nash, non-alcoholic steatohepatitis, prevalence
Online Access:	https://www.gastro-j.ru/jour/article/view/1036
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EPIDEMIOLOGICAL FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN NOVOSIBIRSK (SIBERIAN FEDERAL DISTRICT): REGIONAL DATA OF OPEN MULTICENTER PROSPECTIVE STUDY DIREG 2
by: V. V. Tsukanov, et al.
Published: (2016-09-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN REPUBLIC OF BASHKORTOSTAN (REGIONAL RESULTS OF DIREG 2 STUDY)
by: D. Kh. Kalimullina, et al.
Published: (2017-03-01)

THE PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN OUTPATIENTS IN THE FAR EAST FEDERAL DISTRICT
by: V. A. Nevzorova, et al.
Published: (2017-05-01)

NON-ALCOHOLIC FATTY LIVER DISEASE OUTCOMES FUNNEL
by: D. V. Blinov
Published: (2015-12-01)

Antifibrotic therapies for metabolic dysfunction-associated steatotic liver diseaseKeypoints
by: Robert F. Schwabe, et al.
Published: (2025-08-01)

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease
by: N. V. Bivalkevich, et al.
Published: (2015-09-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

Angiogenesis in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: Gavrilyuk O.M.
Published: (2013-12-01)

Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
by: V. T. Ivashkin, et al.
Published: (2025-03-01)

A Scientometric Assessment of MAFLD in Children and Adolescents from 2007–2024
by: Raju Vaishya, et al.
Published: (2025-07-01)

Epidemiologic features of non-alcoholic fatty liver disease in Russia
by: O. M. Drapkina, et al.
Published: (2014-10-01)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
by: A. V. Bogolyubova, et al.
Published: (2019-12-01)

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion
by: V. V. Tsukanov, et al.
Published: (2023-11-01)

Features of eating behavior in children with different forms of non-alcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2021-09-01)

Non-alcoholic fatty liver disease and cardiovascular pathology: pathogenetic parallels
by: G. Yu. Knorring, et al.
Published: (2024-08-01)

STATIN SAFETY REVISITED DATA
by: O. M. Drapkina
Published: (2015-09-01)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
by: T. E. Promenasheva, et al.
Published: (2014-09-01)

Reactive Oxygen Species as Key Molecules in the Pathogenesis of Alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease: Future Perspectives
by: Zhiqing Zhang, et al.
Published: (2025-06-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)

Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors
by: Ignatius Bima Prasetya, et al.
Published: (2017-08-01)

Association of the p.I148m polymorphism in the <i>PNPLA3</i> gene with the severity of nonalcoholic fatty liver disease in various clinical groups
by: D. V. Sidorenko, et al.
Published: (2024-04-01)

Prevalence of non-alcoholic fatty liver disease among inflammatory bowel disease patients: a systematic review and meta-analysis
by: Yuyang Zhao, et al.
Published: (2025-07-01)

The action of Poria cocos polysaccharides against non-alcoholic fatty liver disease: A preliminary study
by: Rui Zhou, et al.
Published: (2025-12-01)

Genetic aspects of non-alcoholic fatty liver disease development
by: V. A. Akhmedov, et al.
Published: (2021-06-01)

New aspects of non-alcoholic fatty liver disease
by: V. V. Tsukanov, et al.
Published: (2015-09-01)

Liver Cirrhosis as the Outcome of Non-Alcoholic Fatty Liver Disease Associated with PNPLA3 Gene RS738409 Polymorphism
by: I. G. Nikitin, et al.
Published: (2020-03-01)

Non-Alcoholic Fatty Liver Disease, Bile Acids and Intestinal Microbiota
by: R. V. Maslennikov, et al.
Published: (2018-09-01)

Comparative Effectiveness of Bariatric Surgery Versus GLP‐1 Receptor Agonists in Reducing the Risk of New‐Onset of NASH: A Retrospective Multinational Cohort Study From North America and Europe
by: Abdallah Hussein, et al.
Published: (2025-07-01)

The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients
by: I. V. Mayev, et al.
Published: (2013-03-01)

Mineral Water Tib-2 in Treatment of Patients with Nonalcoholic Steatohepatitis
by: N. V. Efimenko, et al.
Published: (2012-09-01)

Changes in rat liver fatty acid profile in experimental non-alcoholic steatohepatitis
by: E. B. Shustov, et al.
Published: (2021-12-01)

An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis
by: M. Imawari, et al.
Published: (2023-11-01)

PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AMONG OBESE PREGNANT WOMEN
by: I. O. Makarov, et al.
Published: (2016-09-01)

Identification of immune and major depressive disorder-related diagnostic markers for early nonalcoholic fatty liver disease by WGCNA and machine learning
by: Yuyun Jia, et al.
Published: (2025-06-01)

Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01)

Analysis of prevalence of risk factor of nonalcoholic fatty liver disease in the Buryat Republic
by: E. G. Naydanova
Published: (2015-04-01)

Narcolepsy Is Associated With Subclinical Cardiovascular Disease as Early as Childhood: A Big Data Analysis
by: Christopher N. Kaufmann, et al.
Published: (2025-06-01)

Metabolic Syndrome in Adults with Nonalcoholic Fatty Liver Disease
by: Zhahid Hassan, et al.
Published: (2021-09-01)

Prevalence of non-alcoholic fatty liver disease among the working-age population: associations with socio-demographic indicators and behavioral risk factors (ESSE RF-2 data)
by: S. E. Evstifeeva, et al.
Published: (2022-10-01)

Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
by: Roger F. Butterworth, et al.
Published: (2019-03-01)